Seeding of amyloid fi brils into fresh solutions of the same peptide or protein in disaggregated form leads to the formation of replicate fi brils [1], with close structural similarity or identity to the original fibrillar seeds. Here we describe procedures for isolating fibrils composed mainly of β-amyloid (Aβ) from human brain and from leptomeninges, a source of cerebral blood vessels, for investigating Alzheimer’s disease and cerebral amyloid angiopathy. We also describe methods for seeding isotopically labeled, disaggregated Aβ peptide solutions for study using solid-state NMR and other techniques. These methods should be applicable to other types of amyloid fibrils, to Aβ fibrils from mice or other species, tissues other than brain, and to some non-fibrillar aggregates. These procedures allow for the examination of authentic amyloid fi brils and other protein aggregates from biological tissues without the need for labeling the tissue.
CITATION STYLE
Scherpelz, K. P., Lu, J. X., Tycko, R., & Meredith, S. C. (2016). Preparation of amyloid fibrils seeded from brain and meninges. In Methods in Molecular Biology (Vol. 1345, pp. 299–312). Humana Press Inc. https://doi.org/10.1007/978-1-4939-2978-8_20
Mendeley helps you to discover research relevant for your work.